找不到产品?留下需求帮您找
一键询价MKN1 人胃癌细胞 QCH812
一周
3500¥
Phoenix-AMPHO 人肾上皮细胞 QCH813
一周
5500¥
DBTRG-05MG 人脑胶质细胞瘤细胞 QCH814
一周
3500¥
SNU638 人胃癌细胞 QCH815
一周
3500¥
NCI-H2073 人非小细胞肺癌细胞 QCH816
一周
5500¥
HAL01 人急性淋巴细胞白血病细胞 QCH817
一周
2500¥
TMD8 人弥漫性大B细胞淋巴瘤 QCH818
一周
7500¥
SNU484 人胃癌细胞 QCH819
一周
3500¥
JHH2 人肝癌细胞 QCH820
一周
4500¥
LK2 人肺腺癌细胞 QCH821
钦诚生物 | 一周
3500¥
公告提醒:爱必信所有产品和服务仅用于科学研究,不用于临床应用及其他用途提供产品和服务(也不为任何个人提供产品和服务)!
抑制剂描述: 产品名称:Nafamostat mesylate 产品别名:见爱必信官网 英文别名:Nafamostat mesylate 靶点:Ser/Thr Protease CAS:82956-11-4 纯度:99% 外观:见爱必信官网 保存方法:store at -20℃ for one year(Powder); in DMSO or others solvent store at 2-4℃ for two weeks, at -20℃ for six months. 描述: Nafamostat mesilate is a synthetic serine protease inhibitor, used as an anticoagulant during hemodialysis. 溶解性:DMSO : 54 mg/mL (100 mM) 体外研究: Nafamostat mesilate significantly inhibits the release of platelet beta-thromboglobulin (beta TG) at 60 and 120 min. Nafamostat mesilate (NM) prevents any significant release of neutrophil elastase; at 120 min, plasma elastase-alpha 1-antitrypsin complex is 0.16 mg/mL in the NM group and 1.24 mg/mL in the control group. Nafamostat mesilate completely inhibits formation of complexes of C1 inhibitor with kallikrein and FXIIa. Nafamostat mesilate inhibits several proteases which may be importantly involved in the pathophysiology of disseminated intravascular coagulation (DIC).Nafamostat mesilate inhibits extrinsic pathway activity (TF-F.VIIa mediated-F.Xa generation) in a concentration dependent manner with IC50 of 0.1 μM. Nafamostat mesilate produces concentration-dependent inhibition of the initial-phase transient component of biphasic ASIC3 currents with an IC50 value of approximately 2.5 mM. 体内研究:Nafamostat mesilate (10 mg/kg) inhibits scratching induced by tryptase but not by histamine and serotonin. Nafamostat mesilate (1-10 mg/kg) produces the dose-dependent inhibition of scratching induced by intradermal compound 48/80 (10 mg/site). Nafamostat mesilate (10 mg/kg) suppresses tryptase activity in the mouse skin. Nafamostat mesilate inhibits gemcitabine-induced NF-kappaB activation, enhances apoptosis by gemcitabine and suppresses pancreatic tumor growth. Nafamostat mesilate combined with Gemcitabine improves the body weight loss of mice induced by Gemicitabine.
产品信息订购:
|